Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HON | GEV |
|---|---|---|
| Price | $211.46 | $953.50 |
| Change today | ▼ 0.52% | ▲ 0.18% |
| Market cap | $67.02B | $253.95B |
| Return, 3 months | -14.6% | -9.8% |
| Return, year to date | +0.6% | +46.2% |
| Return, 1 year | +0.5% | +51.9% |
| P/E (TTM) | 8.2 | 27.3 |
| P/B | 3.6 | 21.2 |
| P/E percentile vs own 5y | 0th | 13th |
| Dividend yield | 4.45% | 0.21% |
| Revenue growth (YoY, latest qtr) | +4.3% | +21.9% |
| Net profit growth (YoY) | +262.4% | +31.9% |
| Gross margin | 36.5% | 20.2% |
| Operating margin | 17.1% | 4.4% |
| Net margin | 21.6% | 23.0% |
| Return on equity | 47.4% | 91.5% |
| Analyst target vs. price | +24.9% | +31.1% |
| Analyst buy share | 67% | 89% |
| RSI (14) | 48 | 49 |
| 30-day volatility | 21.7% | 47.5% |
| Max drawdown, 1 year | -25.0% | -25.5% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.